We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Huaizhong Health Group Inc (CE) | USOTC:ADAD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.11 | 0.00 | 01:00:00 |
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 7, 2019
ADAIAH DISTRIBUTION INC. |
(Exact name of registrant as specified in its charter) |
Nevada |
|
000-55369 |
|
90-1020141 |
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
C/O
YOSEF YAFE
BET ISRAEL 4
JERUSALEM
ISRAEL
(Address of principal executive offices, including zip code.)
972-52-5408519
(Telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
|
|
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.
On April 25, 2019, the eighth judicial District Court of Nevada appointed Yosef Yafe as custodian for the Company, proper notice having been given. There was no opposition. Pursuant to the Order of Custodianship, a Special Meeting of Shareholders was held on May 29, 2019 at 8:00 a.m. PST, Yosef Yafe as limited custodian. Notice was sent May 13, 2019 in compliance with Court Order. Present were Yosef (holding shares through Cede & Co.) and two additional proxies also holding shares through Cede & Co.). A Special Meeting of the Board of Directors (by written consent) on May 31, 2019 was held electing Yosef as all officers, changing the Registered Agent to Holly, Driggs, Walch law firm , and approving a loan from Yosef to the Company evidenced by a Promissory Note dated May 31, 2019 for $3,231.00 to cover expenses paid by Yosef.
Mr Yafe is an entrepreneur with extensive business experience in the retail industry and in the real estate industry and is currently engaged in the business of real estate development in Israel. He also has experience in fundraising for startup companies and assisting early stage startups and other companies to enhance their business strategy and business plan. He studied in Jerusalem Israel and is of the age of 31.
Family Relationships
Mr. Yafe has no family relationship with any of the previous officers or directors of the Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
ADAIAH DISTRIBUTION INC |
|
|
|
|
||
Date: August 7, 2019 |
By: |
/s/ Yosef Yafe |
|
|
Name: |
Yosef Yafe |
|
|
Title: |
Chief Executive Officer |
|
3 |
1 Year Huaizhong Health (CE) Chart |
1 Month Huaizhong Health (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions